Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease | Zendy

Satish Kumar Ramraj | Zendy; Sheeja Aravindan | Zendy; Dinesh Babu Somasundaram | Zendy; Terence S. Herman | Zendy; Mohan Natarajan | Zendy; Natarajan Aravindan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease

Author(s) -

Satish Kumar Ramraj,

Sheeja Aravindan,

Dinesh Babu Somasundaram,

Terence S. Herman,

Mohan Natarajan,

Natarajan Aravindan

Publication year - 2016

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.7615

Subject(s) - microrna , neuroblastoma , biomarker , tumor progression , medicine , gene silencing , oncology , disease , cancer research , metastasis , cancer , bioinformatics , biology , genetics , gene , cell culture

Circulating miRNAs have momentous clinical relevance as prognostic biomarkers and in the progression of solid tumors. Recognizing novel candidates of neuroblastoma-specific circulating miRNAs would allow us to identify potential prognostic biomarkers that could predict the switch from favorable to high-risk metastatic neuroblastoma (HR-NB).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research